How Remazing Delivered +84% New-to-Brand Sales Across Europe for OMRON’s Largest-Ever Amazon Relaunch
When OMRON Healthcare began a relaunch on Amazon across Europe, the scale of the challenge was clear from the start. Its best-selling medical devices were revenue drivers in five markets. Replacing them meant building awareness, consideration, and conversion from scratch during Q4’s most competitive sales period across France, the UK, Germany, Italy, and Spain simultaneously.
In Germany, the loss of Stiftung Warentest certification added another layer of complexity. For German consumers, that certification had been a primary trust signal. Without it, new ASINs were entering one of OMRON’s most important markets without the organic visibility, conversion rates, and customer trust built over years that had made previous products credible.
Europe’s Biggest Healthcare Relaunch. Five Markets. No Historical Baseline
OMRON and Remazing set a clear ambition: exceed +25% branded search impression growth in every EU5 market, drive substantial new-to-brand acquisition in Q4 2025, and convert that demand into revenue growth in Q1 2026. New ASINs needed to compete against established competitors and OMRON’s own legacy positioning, without the review history, ranking, or certification status that typically take years to develop.
Five Markets. AI-Driven Optimization. One Continuously Learning Campaign.
Remazing designed an AI-enhanced, full-funnel strategy connecting awareness, consideration, and conversion across five markets, with Skai’s AI automation running continuous optimization throughout.
At the upper funnel, the agency activated Streaming TV across Amazon Prime Video and Fire TV, alongside Online Video across Amazon and the open web. External data providers, including Acxiom in Germany, enabled precise targeting of older demographics and caregivers most likely to purchase. Creative Agent enabled rapid script adaptation and scalable creative production across markets.
AMC connected the full picture: audience creation, path-to-purchase analysis, sequencing, frequency management, and incrementality measurement. From those insights, the team built AI-driven dayparting strategies for Sponsored Ads, automatically shifting bids toward the highest-converting windows. When demand was strongest, spend followed. When it softened, bids pulled back without manual intervention.
Skai’s automated placement optimization continuously reallocated bids across Top of Search, Product Detail Pages, and Rest of Search based on live performance signals. Negative keyword harvesting excluded non-converting queries over time, improving traffic quality and ROAS as the campaign progressed. And Budget Navigator managed spend across multiple product categories in real time across all five markets simultaneously, rather than having to manage spend in isolated silos. By the end of the activation, the campaign was performing meaningfully better than it had at launch.
Results
The campaign exceeded its targets in every EU5 market:
- +61% YoY branded search impressions in France | +34% UK | +33% Germany | +32% Italy | +27% Spain
- +80% increase in advertising-driven Detail Page Views versus the two months prior
- +10.8% total EU5 revenue growth YoY was more than double the original target
- +84% EU5 new-to-brand sales growth
- Full-funnel purchase rates up to 19%, versus an 8% historical baseline
About Remazing
Remazing is Europe’s largest independent marketplace group, supporting ambitious brands across 30+ international markets through specialized marketplace expertise, retail media, content, and operations.
About OMRON Healthcare
OMRON Healthcare is a global healthcare company specializing in clinically validated medical devices and health monitoring solutions, including blood pressure monitors, respiratory therapy devices, and body composition monitors.
Solution Used
